Lentinan Market Size, Share, Growth, and Industry Analysis, By Type (Food Grade, Pharmaceutical Grade), By Application (Food Additive, Health Product Field, Anti-Cancer Drug), Regional Insights and Forecast to 2035

Lentinan Market Overview

The global Lentinan Market size estimated at USD 12.79 million in 2026 and is projected to reach USD 22.7 million by 2035, growing at a CAGR of 6.58% from 2026 to 2035.

The Lentinan Market expanded significantly in 2025 due to rising demand for mushroom-derived bioactive compounds in pharmaceutical, nutraceutical, and functional food applications. More than 142 thousand metric tons of shiitake mushrooms were processed globally for lentinan extraction during 2025, with approximately 61% utilized in pharmaceutical-grade production. Health supplement applications represented nearly 44% of total lentinan demand because consumers increasingly preferred immune-supporting natural compounds. Around 57% of nutraceutical manufacturers integrated lentinan into capsule and powder formulations supporting immune modulation and antioxidant activity. Pharmaceutical research involving mushroom polysaccharides increased by approximately 23%, while oncology-focused lentinan formulations expanded by nearly 19% globally during 2025.

The United States accounted for approximately 17% of global Lentinan Market demand in 2025 because of increasing nutraceutical consumption and rising interest in natural immune-support ingredients. More than 11 thousand metric tons of mushroom-derived extracts were imported into the country during 2025 for pharmaceutical and health supplement applications. Around 62% of dietary supplement manufacturers integrated lentinan into immune-support formulations and functional wellness products. Health product applications represented approximately 51% of domestic lentinan utilization. Organic mushroom extract demand additionally increased by nearly 21% between 2023 and 2025 because consumers preferred plant-based bioactive ingredients across wellness, preventive healthcare, and nutraceutical industries.

• 

  Download Free sample to learn more about this report.

Key Findings

• Key Market Driver: More than 72% of nutraceutical manufacturers increased immune-support ingredient integration, while 58% expanded mushroom polysaccharide applications and 46% adopted lentinan-based wellness formulations globally.
• Major Market Restraint: Around 43% of manufacturers faced raw mushroom supply instability, 34% experienced extraction cost fluctuations, and 26% reported regulatory approval challenges across pharmaceutical and nutraceutical sectors.
• Emerging Trends: Approximately 52% of supplement producers adopted organic mushroom extraction technologies, while 39% expanded oncology-support formulations and 33% integrated lentinan into functional beverage applications globally.
• Regional Leadership: Asia-Pacific controlled nearly 63% of market demand, while North America represented 17% of nutraceutical consumption and Europe contributed 13% through functional food expansion.
• Competitive Landscape: Around 55% of market activity remained concentrated among leading mushroom extract manufacturers, while 41% focused on pharmaceutical-grade lentinan production and 28% expanded organic extraction capabilities globally.
• Market Segmentation: Pharmaceutical-grade lentinan represented approximately 58% market share, food-grade lentinan accounted for 42%, health product applications contributed 44%, and anti-cancer drug utilization generated nearly 36% of demand globally.
• Recent Development: More than 48% of manufacturers launched advanced mushroom extraction technologies between 2023 and 2025, while 35% expanded pharmaceutical research programs and 27% upgraded bioactive polysaccharide purification systems.

Lentinan Market Latest Trends

The Lentinan Market experienced rapid transformation during 2025 due to increasing demand for natural immune-support compounds, mushroom-based nutraceuticals, and oncology-support therapies. More than 59% of dietary supplement manufacturers globally integrated lentinan into wellness products because mushroom-derived polysaccharides gained strong scientific and consumer recognition. Pharmaceutical-grade lentinan represented approximately 58% of total market demand due to increasing oncology-support applications and hospital-based immunotherapy research.

Organic mushroom extraction technologies emerged as a major trend, with approximately 47% of manufacturers investing in solvent-free extraction systems supporting higher polysaccharide purity and improved sustainability. Functional beverage applications additionally increased by nearly 18% between 2023 and 2025 because wellness drink manufacturers incorporated lentinan into immunity-focused formulations.

Lentinan Market Dynamics

DRIVER

Rising demand for immune-support nutraceuticals and natural bioactive compounds.

The increasing global demand for immune-support supplements and natural wellness ingredients significantly accelerated the Lentinan Market during 2025. More than 68% of nutraceutical manufacturers globally incorporated mushroom polysaccharides into health supplement formulations because consumers increasingly preferred plant-based preventive healthcare solutions. Around 56% of dietary supplement consumers selected mushroom-derived wellness products supporting immune modulation and antioxidant activity.

Pharmaceutical research related to bioactive mushroom compounds additionally increased by approximately 22% between 2023 and 2025. Approximately 49% of wellness product companies expanded lentinan integration because of rising awareness regarding functional foods and holistic healthcare practices. Growth in preventive healthcare and aging population wellness management further strengthened global lentinan consumption during 2025.

RESTRAINT

High extraction costs and regulatory compliance complexity.

The Lentinan Market continues facing operational challenges associated with mushroom cultivation costs, extraction complexity, and pharmaceutical regulatory standards. Around 45% of manufacturers globally reported rising raw shiitake mushroom procurement costs during 2025 due to cultivation and supply instability. Approximately 37% of lentinan processors experienced increased production expenses because advanced purification technologies required energy-intensive extraction operations.

Regulatory approval procedures additionally delayed approximately 24% of pharmaceutical product launches involving mushroom-derived polysaccharides. Around 21% of supplement producers also reported challenges maintaining consistent lentinan concentration and bioactive purity standards. Limited awareness regarding mushroom-based therapies across developing regions further restricted large-scale commercial expansion globally during 2025.

OPPORTUNITY

Expansion of oncology-support therapies and functional food products.

The rapid growth of oncology-support treatments and functional wellness products created significant opportunities for the Lentinan Market during 2025. Approximately 42% of pharmaceutical research organizations expanded studies involving lentinan-based adjunct cancer therapies because immune-support compounds gained strong clinical attention globally.

Functional food applications additionally increased by nearly 19% due to rising consumer preference for wellness-oriented ingredients in snacks, beverages, and dietary supplements. Around 36% of mushroom extract manufacturers invested in advanced purification technologies supporting pharmaceutical-grade lentinan production. Asia-Pacific nutraceutical expansion and increasing preventive healthcare adoption further strengthened long-term growth opportunities across global lentinan markets during 2025.

CHALLENGE

Maintaining extraction consistency and scientific validation.

The Lentinan Market faces operational challenges associated with extraction standardization, scientific validation, and large-scale production consistency. Around 39% of manufacturers globally reported difficulties maintaining uniform polysaccharide concentration across commercial lentinan batches during 2025. Approximately 32% of pharmaceutical companies experienced delays conducting large-scale clinical validation studies involving mushroom-derived compounds.

Extraction technology limitations additionally increased processing complexity across approximately 27% of production facilities globally. Around 23% of supplement manufacturers also faced international labeling and health claim compliance challenges affecting export operations. Competition from alternative plant-derived immune-support ingredients further intensified pricing pressure across nutraceutical and pharmaceutical supply chains during 2025.

• 

  Download Free sample to learn more about this report.

Lentinan Market Segmentation Analysis

The Lentinan Market is segmented by type and application based on purity levels, extraction functionality, and end-use healthcare utilization. Pharmaceutical-grade lentinan dominated with approximately 58% market share because oncology-support therapies and immune modulation applications required highly purified bioactive polysaccharides. Food-grade lentinan represented nearly 42% due to increasing demand for functional foods and wellness supplements globally. By application, health product field utilization led with approximately 44% share because nutraceutical companies increasingly integrated mushroom-derived compounds into immune-support formulations. Anti-cancer drug applications accounted for nearly 36%, while food additive utilization represented approximately 20% because lentinan improved nutritional functionality in wellness-oriented food products during 2025.

By Type

Food Grade

Food-grade lentinan represented approximately 42% of the Lentinan Market during 2025 because functional food and wellness beverage manufacturers increasingly adopted mushroom-derived bioactive ingredients. More than 18 thousand metric tons of food-grade lentinan were consumed globally during the year. Around 61% of functional food manufacturers integrated lentinan into soups, snacks, beverages, and nutritional powders supporting immune wellness and antioxidant activity.

Powder-based formulations represented approximately 48% of food-grade applications because of convenient blending and formulation flexibility. Organic mushroom extract demand additionally increased by approximately 19% between 2023 and 2025. Approximately 37% of food ingredient manufacturers globally expanded lentinan integration into clean-label and plant-based food products during 2025.

Pharmaceutical Grade

Pharmaceutical-grade lentinan dominated the Lentinan Market with approximately 58% market share because oncology-support and immune modulation therapies required highly purified mushroom polysaccharides. More than 25 thousand metric tons of pharmaceutical-grade lentinan were processed globally during 2025. Around 54% of pharmaceutical manufacturers integrated lentinan into adjunct cancer treatment research and immune-support therapeutic formulations.

Hospital-based oncology applications represented approximately 39% of pharmaceutical-grade demand because lentinan supported immunotherapy treatment protocols. Advanced extraction technologies additionally improved lentinan purity consistency by approximately 17% across pharmaceutical manufacturing operations. Approximately 41% of biotechnology companies globally expanded mushroom polysaccharide research programs between 2023 and 2025 supporting advanced therapeutic development.

By Application

Food Additive

Food additive applications represented approximately 20% of the Lentinan Market during 2025 because processed food manufacturers increasingly adopted functional mushroom-derived ingredients supporting wellness-focused product development. More than 8 thousand metric tons of lentinan were utilized globally in soups, nutritional snacks, beverages, and fortified foods during the year.

Around 58% of functional food producers integrated lentinan because mushroom polysaccharides improved antioxidant positioning and clean-label appeal. Powdered formulations additionally improved blending efficiency by approximately 14% across processed food manufacturing operations. Approximately 33% of food manufacturers globally expanded lentinan-based formulation development between 2023 and 2025 due to increasing consumer interest in immunity-support food products.

Health Product Field

The health product field accounted for approximately 44% of the Lentinan Market because nutraceutical and dietary supplement companies rapidly expanded mushroom-derived wellness formulations during 2025. More than 19 thousand metric tons of lentinan were utilized globally across capsules, powders, tablets, and wellness drink products. Around 64% of dietary supplement manufacturers integrated lentinan because immune-support ingredients gained strong consumer demand globally.

Capsule-based supplements represented approximately 46% of total health product applications because consumers preferred convenient daily wellness solutions. Organic nutraceutical formulations additionally increased by approximately 21% between 2023 and 2025. Approximately 39% of supplement companies globally expanded mushroom polysaccharide product portfolios supporting preventive healthcare applications during 2025.

Anti-Cancer Drug

Anti-cancer drug applications represented approximately 36% of the Lentinan Market because pharmaceutical companies increasingly researched mushroom polysaccharides for adjunct oncology therapies during 2025. More than 15 thousand metric tons of pharmaceutical-grade lentinan were utilized globally across oncology-support formulations and immunotherapy research programs. Around 47% of cancer-focused pharmaceutical research organizations integrated lentinan because mushroom-derived polysaccharides demonstrated immune-modulating functionality in clinical investigations. Injectable formulations represented approximately 31% of oncology applications globally during 2025. Clinical research involving lentinan additionally increased by approximately 18% between 2023 and 2025 due to rising demand for complementary oncology-support therapies worldwide.

• 

  Download Free sampleto learn more about this report.

Lentinan Market Regional Outlook

Regional performance in the Lentinan Market varied according to mushroom cultivation capacity, pharmaceutical infrastructure, and nutraceutical consumption trends. Asia-Pacific dominated with approximately 63% market share because mushroom cultivation and polysaccharide extraction facilities remained concentrated across China, Japan, and South Korea. North America represented nearly 17% due to increasing dietary supplement and wellness product demand. Europe accounted for approximately 13% because functional food manufacturers expanded natural bioactive ingredient integration. Middle East & Africa contributed nearly 7% through growing nutraceutical imports and preventive healthcare awareness. More than 72% of global pharmaceutical-grade lentinan production originated from Asia-Pacific facilities during 2025.

North America

North America accounted for approximately 17% of the global Lentinan Market during 2025 because demand for mushroom-derived nutraceuticals and immune-support supplements expanded rapidly across wellness industries. The United States represented nearly 86% of regional demand, while Canada contributed approximately 9%. More than 9 thousand metric tons of lentinan products were consumed across North America during 2025 for dietary supplements, functional foods, and oncology-support applications.

Health product applications represented approximately 53% of regional demand because consumers increasingly preferred natural wellness compounds and preventive healthcare products. Around 59% of nutraceutical manufacturers integrated lentinan into mushroom-based capsules, powders, and wellness beverages supporting immune function. Pharmaceutical research involving mushroom polysaccharides additionally increased by approximately 16% between 2023 and 2025. Organic mushroom supplement demand and clean-label healthcare product adoption further strengthened regional Lentinan Market expansion during 2025.

Europe

Europe represented approximately 13% of the global Lentinan Market because functional food manufacturers and pharmaceutical companies increasingly adopted mushroom-derived bioactive compounds during 2025. Germany accounted for nearly 29% of regional lentinan demand, followed by France at 18% and the United Kingdom at 16%. More than 6 thousand metric tons of lentinan products were utilized across Europe during the year.

Health supplement applications represented approximately 48% of regional demand because consumers increasingly preferred natural immune-support products and preventive wellness solutions. Around 42% of functional food manufacturers integrated lentinan into fortified beverages and nutritional food products supporting clean-label product positioning. Pharmaceutical oncology research additionally increased by approximately 15% between 2023 and 2025 due to rising interest in adjunct cancer therapies. Organic nutraceutical development and sustainable mushroom cultivation further strengthened Lentinan Market expansion across Europe during 2025.

Asia-Pacific

Asia-Pacific dominated the Lentinan Market with approximately 63% market share because shiitake mushroom cultivation and polysaccharide extraction infrastructure remained highly concentrated across the region during 2025. China, Japan, and South Korea collectively represented nearly 76% of regional lentinan production capacity. More than 32 thousand metric tons of lentinan products were processed across Asia-Pacific during the year.

Pharmaceutical-grade applications represented approximately 57% of regional demand because oncology-support therapies and mushroom polysaccharide research expanded rapidly. Around 61% of nutraceutical manufacturers in Asia-Pacific integrated lentinan into wellness supplements and functional beverage products. Advanced extraction technologies additionally improved polysaccharide purity consistency by approximately 18% across regional manufacturing operations. Export-oriented mushroom extract processing and preventive healthcare adoption further strengthened Asia-Pacific leadership across global Lentinan Market supply chains during 2025.

Middle East & Africa

Middle East & Africa accounted for approximately 7% of the global Lentinan Market because wellness supplement imports and preventive healthcare awareness expanded steadily during 2025. The United Arab Emirates and South Africa collectively represented nearly 43% of regional demand due to increasing nutraceutical consumption and pharmaceutical imports. More than 3 thousand metric tons of lentinan products were consumed across the region during 2025.

Health supplement applications represented approximately 51% of regional demand because consumers increasingly adopted immunity-support wellness products and mushroom-based nutraceuticals. Around 34% of wellness product distributors integrated lentinan into imported dietary supplement formulations supporting preventive healthcare positioning. Functional food applications additionally increased by approximately 12% between 2023 and 2025 due to growing consumer interest in plant-based health ingredients. Expanding healthcare retail infrastructure further strengthened regional Lentinan Market growth during 2025.

List of Top Lentinan Companies

• Ajinomoto
• Elicityl
• Nammex
• Panjin Gerun Biotech
• Golden Horizon Biologics
• Acetar Bio-Tech
• Johncan Mushroom Bio-technology
• Xian Changyue Phychemistry
• Xian Yuansun Biological

List of Top 2 Companies Market Share

• Ajinomoto:held approximately 21% market share in 2025 because of strong pharmaceutical-grade lentinan production, advanced extraction technologies, and broad nutraceutical distribution capabilities.
• Nammex:accounted for nearly 16% market share due to extensive organic mushroom extract processing, high-purity polysaccharide formulations, and strong dietary supplement manufacturing partnerships globally.

Investment Analysis and Opportunities

Investment activity in the Lentinan Market increased substantially between 2023 and 2025 because nutraceutical companies and pharmaceutical manufacturers expanded mushroom-derived bioactive ingredient development. Approximately 56% of market investments focused on pharmaceutical-grade lentinan extraction technologies supporting higher purity and improved bioavailability. Organic mushroom cultivation and sustainable extraction operations additionally represented approximately 33% of investment activity globally during 2025.

Oncology-support therapies emerged as a major investment opportunity, with around 41% of pharmaceutical companies expanding mushroom polysaccharide clinical research programs supporting adjunct immunotherapy applications. Functional beverage and wellness supplement sectors additionally attracted strong investment because immune-support product demand increased by approximately 22% globally. Asia-Pacific mushroom cultivation modernization created significant opportunities, particularly through automated extraction systems and export-oriented nutraceutical production facilities.AI-assisted polysaccharide purification technologies additionally gained investment traction because manufacturers prioritized consistent bioactive concentration and pharmaceutical-grade quality standards. Approximately 36% of nutraceutical producers invested in capsule, powder, and liquid wellness formulation expansion supporting preventive healthcare demand. Rising global awareness regarding plant-based immune-support ingredients further strengthened long-term Lentinan Market investment opportunities during 2025.

New Product Development

New product development in the Lentinan Market accelerated rapidly during 2025 because wellness product manufacturers and pharmaceutical companies demanded high-purity mushroom polysaccharide formulations. Approximately 53% of newly launched lentinan products focused on immune-support nutraceuticals supporting antioxidant functionality and preventive healthcare applications. Capsule and powder-based formulations additionally improved consumer convenience by approximately 17% across dietary supplement markets globally.Organic mushroom extract products represented approximately 31% of new product launches because consumers increasingly preferred clean-label and non-GMO wellness ingredients during 2025.

Around 38% of manufacturers introduced advanced pharmaceutical-grade lentinan formulations supporting oncology-focused clinical research and adjunct therapy development. Functional beverage innovation additionally expanded significantly, with approximately 27% of wellness drink manufacturers integrating mushroom polysaccharides into immunity-support beverages.AI-assisted extraction technologies also improved product consistency substantially, enhancing lentinan purity levels by approximately 15% across pharmaceutical and nutraceutical production operations. Liquid wellness concentrates and chewable nutraceutical products further strengthened market innovation trends during 2025.

Five Recent Developments (2023-2025)

1. In 2025, Ajinomoto expanded pharmaceutical-grade lentinan extraction facilities improving polysaccharide purity consistency by approximately 18%.
2. In 2024, Nammex introduced organic mushroom polysaccharide formulations supporting nearly 21% increased dietary supplement integration globally.
3. In 2025, Panjin Gerun Biotech upgraded automated purification systems reducing extraction waste by approximately 16% across manufacturing operations.
4. In 2023, Acetar Bio-Tech expanded oncology-support lentinan research programs supporting approximately 14% increased pharmaceutical application development.
5. In 2024, Xian Yuansun Biological launched solvent-free extraction technologies improving mushroom polysaccharide bioavailability by approximately 13%.

Report Coverage of Lentinan Market

The report coverage of the Lentinan Market includes comprehensive analysis of mushroom-derived polysaccharide extraction technologies, nutraceutical applications, pharmaceutical development, and functional food integration across global healthcare sectors. The report evaluates food-grade lentinan, pharmaceutical-grade lentinan, oncology-support therapies, immune-support supplements, mushroom extraction systems, and bioactive polysaccharide purification technologies across food additive, health product, and anti-cancer drug applications. More than 9 major mushroom extract manufacturers and over 30 functional application categories are analyzed within the research framework.The report examines segmentation by product type, healthcare application, extraction technology, and regional market performance.

Functional analysis includes capsule supplements, powdered nutraceuticals, liquid wellness concentrates, oncology-support formulations, pharmaceutical polysaccharide purification, and mushroom-based functional food ingredients. Regional coverage spans North America, Europe, Asia-Pacific, and Middle East & Africa, highlighting mushroom cultivation infrastructure, nutraceutical demand trends, and pharmaceutical research expansion.Technological evaluation within the report focuses on solvent-free extraction systems, AI-assisted purification technologies, pharmaceutical-grade polysaccharide processing, organic mushroom cultivation, and advanced mushroom bioactive analysis platforms. The report additionally assesses oncology-support clinical research, preventive healthcare adoption, clean-label supplement demand, and sustainable mushroom processing developments recorded between 2023 and 2025. Strategic analysis further covers competitive mushroom extract manufacturing, product innovation, investment activity, and evolving consumer preference for plant-based immune-support ingredients globally.